| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8776365 | Urology | 2017 | 18 Pages |
Abstract
This initial clinical experience with TU 750âmg provides evidence for good patient satisfaction and persistence with treatment, together with a favorable safety profile. Optimal dosing may be less than 10 weeks for some individuals.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Yonah Krakowsky, William Conners, Emily Davidson, Alex Rawji, Abraham Morgentaler,